Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119523393 | 11952339 | 3 | F | 20160901 | 20160126 | 20160902 | EXP | CA-ROCHE-1700114 | ROCHE | 73.00 | YR | F | Y | 0.00000 | 20160902 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119523393 | 11952339 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 103792 | 736 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 119523393 | 11952339 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 103792 | 552 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 119523393 | 11952339 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 103792 | 8 | MG/KG | SOLUTION FOR INFUSION | Q3W | |||||
| 119523393 | 11952339 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 103792 | 552 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 119523393 | 11952339 | 5 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 125409 | 840 | MG | Q3W | ||||||
| 119523393 | 11952339 | 6 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 125409 | 420 | MG | Q3W | ||||||
| 119523393 | 11952339 | 7 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 125409 | 420 | MG | Q3W | |||||||
| 119523393 | 11952339 | 8 | SS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 125409 | 420 | MG | Q3W | ||||||
| 119523393 | 11952339 | 9 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 0 | 476 | MG | Q3W | ||||||
| 119523393 | 11952339 | 10 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 0 | 694 | MG | Q3W | ||||||
| 119523393 | 11952339 | 11 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | THERAPY DURATION: 1 DAY | U | 0 | 476 | MG | Q3W | ||||||
| 119523393 | 11952339 | 12 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | Q3W | |||||||||
| 119523393 | 11952339 | 13 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 119 | MG | Q3W | |||||||
| 119523393 | 11952339 | 14 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 119523393 | 11952339 | 15 | C | COVERSYL | PERINDOPRIL | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 16 | C | DECADRON | DEXAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 119523393 | 11952339 | 17 | C | KYTRIL | GRANISETRON HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 119523393 | 11952339 | 18 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 19 | C | ANCEF | CEFAZOLIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 119523393 | 11952339 | 20 | C | CEFADROXIL. | CEFADROXIL | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 21 | C | GRAVOL | DIMENHYDRINATE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 22 | C | HEPARIN SODIUM. | HEPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
| 119523393 | 11952339 | 23 | C | HUMULIN R | INSULIN HUMAN | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 24 | C | K-DUR | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 25 | C | MAGNESIUM GLUCEPTATE | MAGNESIUM GLUCEPTATE | 1 | Oral | 0 | |||||||||||
| 119523393 | 11952339 | 26 | C | MAGNESIUM GLUCONATE | MAGNESIUM GLUCONATE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 27 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 28 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 29 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 0 | ||||||||||||
| 119523393 | 11952339 | 30 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119523393 | 11952339 | 1 | Breast cancer |
| 119523393 | 11952339 | 5 | Breast cancer |
| 119523393 | 11952339 | 9 | Breast cancer |
| 119523393 | 11952339 | 12 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119523393 | 11952339 | LT |
| 119523393 | 11952339 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119523393 | 11952339 | Cellulitis | |
| 119523393 | 11952339 | Clostridium difficile infection | |
| 119523393 | 11952339 | Diarrhoea | |
| 119523393 | 11952339 | Enterocolitis infectious |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |